BE829058A - Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle - Google Patents
Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyleInfo
- Publication number
- BE829058A BE829058A BE156336A BE156336A BE829058A BE 829058 A BE829058 A BE 829058A BE 156336 A BE156336 A BE 156336A BE 156336 A BE156336 A BE 156336A BE 829058 A BE829058 A BE 829058A
- Authority
- BE
- Belgium
- Prior art keywords
- pyroglutamyl
- derivatives
- medicinal product
- psychotropic effect
- psychotropic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2423389A DE2423389A1 (de) | 1974-05-14 | 1974-05-14 | Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
BE829058A true BE829058A (fr) | 1975-11-14 |
Family
ID=5915522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE156336A BE829058A (fr) | 1974-05-14 | 1975-05-14 | Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle |
Country Status (11)
Country | Link |
---|---|
US (1) | US4053588A (nl) |
JP (1) | JPS50157361A (nl) |
BE (1) | BE829058A (nl) |
CA (1) | CA1067410A (nl) |
DE (1) | DE2423389A1 (nl) |
DK (1) | DK207575A (nl) |
FR (1) | FR2270867B1 (nl) |
GB (1) | GB1503680A (nl) |
IE (1) | IE41055B1 (nl) |
LU (1) | LU72449A1 (nl) |
NL (1) | NL7505479A (nl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1492640A (en) * | 1975-07-08 | 1977-11-23 | Ucb Sa | L-pyroglutamyl-l-prolinamide |
JPH0822819B2 (ja) * | 1986-02-28 | 1996-03-06 | ハフスルンド ナイコメド アクチスカベット | 細胞生長調節作用を有するジペプチドを含有する薬学的製剤 |
IT1244548B (it) * | 1991-02-06 | 1994-07-15 | Poli Ind Chimica Spa | Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche |
AU2004266658A1 (en) | 2003-08-12 | 2005-03-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo-containing compounds |
KR101106812B1 (ko) | 2003-08-27 | 2012-01-19 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린 |
EP1660026A4 (en) | 2003-09-05 | 2008-07-16 | 3M Innovative Properties Co | TREATMENT FOR CD5 + B CELL LYMPHOMA |
US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
JP5043435B2 (ja) | 2003-10-03 | 2012-10-10 | スリーエム イノベイティブ プロパティズ カンパニー | アルコキシ置換イミダゾキノリン |
EP1685129A4 (en) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
JP2007511535A (ja) | 2003-11-14 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドロキシルアミン置換イミダゾ環化合物 |
WO2005051317A2 (en) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
US8802853B2 (en) | 2003-12-29 | 2014-08-12 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
JP2007517044A (ja) | 2003-12-30 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド |
WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
WO2006083440A2 (en) | 2004-12-30 | 2006-08-10 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
US7943609B2 (en) | 2004-12-30 | 2011-05-17 | 3M Innovative Proprerties Company | Chiral fused [1,2]imidazo[4,5-C] ring compounds |
AU2005323024A1 (en) * | 2004-12-30 | 2006-07-13 | 3M Innovative Properties Company | Multi-route administration of immune response modifier compounds |
CA2597092A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
EP1846405A2 (en) | 2005-02-11 | 2007-10-24 | 3M Innovative Properties Company | Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods |
JP2008535832A (ja) | 2005-04-01 | 2008-09-04 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ピラゾロピリジン−1,4−ジアミン、およびそのアナログ |
CA2602590A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
DE102014110783A1 (de) * | 2014-07-30 | 2016-02-04 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Zusammensetzung zur Modulation der Aktivität von Nicht-Strukturproteinen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE63496C (de) * | B. A. DOBSON in Bolton, Grafsch. Lancaster, England, und E. APPENZELLER in Alost, Belgien | Krempel mit Verringerung der Geschwindigkeit des Abnehmers beim Zerreifsen des Bandes | ||
US3002978A (en) * | 1958-05-06 | 1961-10-03 | Bocher Gustave Marie Joseph | Glyceryl pyrrolidone carboxylates |
FR2207707A1 (en) * | 1972-11-27 | 1974-06-21 | Fabre Sa Pierre | 2-Pyrrolidone-5-carboxylic acid esters and amides - with sedative and hypnotic activity |
-
1974
- 1974-05-14 DE DE2423389A patent/DE2423389A1/de not_active Withdrawn
-
1975
- 1975-05-09 NL NL7505479A patent/NL7505479A/nl not_active Application Discontinuation
- 1975-05-12 LU LU72449A patent/LU72449A1/xx unknown
- 1975-05-12 GB GB19839/75A patent/GB1503680A/en not_active Expired
- 1975-05-12 US US05/576,715 patent/US4053588A/en not_active Expired - Lifetime
- 1975-05-12 DK DK207575A patent/DK207575A/da not_active Application Discontinuation
- 1975-05-13 CA CA227,257A patent/CA1067410A/en not_active Expired
- 1975-05-13 IE IE1068/75A patent/IE41055B1/xx unknown
- 1975-05-14 FR FR7515027A patent/FR2270867B1/fr not_active Expired
- 1975-05-14 BE BE156336A patent/BE829058A/xx unknown
- 1975-05-14 JP JP50056231A patent/JPS50157361A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK207575A (da) | 1975-11-15 |
GB1503680A (en) | 1978-03-15 |
FR2270867A1 (nl) | 1975-12-12 |
CA1067410A (en) | 1979-12-04 |
IE41055L (en) | 1975-11-14 |
LU72449A1 (nl) | 1977-02-09 |
NL7505479A (nl) | 1975-11-18 |
DE2423389A1 (de) | 1975-12-04 |
FR2270867B1 (nl) | 1978-08-04 |
JPS50157361A (nl) | 1975-12-19 |
US4053588A (en) | 1977-10-11 |
IE41055B1 (en) | 1979-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE829058A (fr) | Medicament ayant un effet psychotrope, a base de derive de l'pyroglutamyle | |
BE854270A (fr) | Medicament anti-tumeur a base de compose du type lysolecithine | |
PH11040A (en) | 1,1-diamino ethylene derivatives and a pharmaceutical composition thereof | |
FR2304348A1 (fr) | Medicament a base de sulfadiazine zincique | |
BE854925A (fr) | Acides 12-azaprostanoiques utiles comme medicament | |
BE866276A (fr) | Composes a cycle beta-lactame, utilisables comme medicament | |
FR2321898A1 (fr) | Medicament contenant un poly-(amino-acide) | |
PH11669A (en) | Thienobenzo(1,5)diazepine derivatives and the pharmaceutical formulation thereof | |
BE883495A (fr) | Medicament hypolipemiqude a base de carnitine | |
BE854072A (fr) | Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament | |
BE844532A (fr) | Medicament a base d'un derive du benzothiadiazole | |
BE827595A (fr) | Medicament a administration par voie orale produisant un effet inhibiteur de l'antiplasmine | |
FR2307541A1 (fr) | Medicament a base d'un polypeptide | |
BE767707A (fr) | Medicament a base d'un derive de l'aminoacetonitrile | |
MC1053A1 (fr) | Medicament comprenant une 2,4-diamino-pyrimidine er un sulfonamide t un sulfonamide | |
BE802995A (fr) | Medicament a base d'un derive de l'oxindole | |
BE865369A (fr) | Medicament a base d'extrait de physarym | |
BE811547A (fr) | Medicament a base d'un derive de la 7h-benzocycloheptene-7-one | |
FR2342067A1 (fr) | Medicament a base d'un derive de la quinoleine | |
BE801014A (fr) | Medicament a base d'(hydroxy-2 indanyl-2)1 propylamine | |
BE771112A (fr) | Medicament a base d'un derive de l'aminoguanidine | |
AU473590B2 (en) | New 1, 4-dihydroquinoline derivatives, theer production, and their medicinal use | |
BE770844A (fr) | Medicament a base d'un derive de diphenyl-alcane | |
FR2282907A1 (fr) | Nouvel amide tetrapeptidique, utile comme medicament | |
IL45655A0 (en) | New n'-(aminoacylaminophenyl)-acetamidenes and salts thereof,their production and their medicinal use |